{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:29:00Z","timestamp":1793158140770,"version":"4.5.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"crossref","award":["IT1512\/22"],"award-info":[{"award-number":["IT1512\/22"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MCIU\/AEI\/FEDER, UE grant","award":["PID2022-141700OB-I00"],"award-info":[{"award-number":["PID2022-141700OB-I00"]}]},{"name":"Fundaci\u00f3 La Marat\u00f3 de TV3 , Catalunya","award":["202207"],"award-info":[{"award-number":["202207"]}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2021-SGR-01358"],"award-info":[{"award-number":["2021-SGR-01358"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-025-03608-y","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:45:43Z","timestamp":1762256743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A molecular convergence in the triad of parkinson\u2019s disease, depressive disorder and gut health is revealed by the inflammation-miRNA axis"],"prefix":"10.1186","volume":"22","author":[{"given":"Lluis","family":"Miquel-Rio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Jeric\u00f3-Escolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Yanes-Castilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unai","family":"Sarri\u00e9s-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Callado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Javier","family":"Meana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analia","family":"Bortolozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"3608_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.neuroscience.2024.12.009","volume":"565","author":"M Absalyamova","year":"2024","unstructured":"Absalyamova M, Traktirov D, Burdinskaya V, Artemova V, Muruzheva Z, Karpenko M. Molecular basis of the development of parkinson\u2019s disease. Neuroscience. 2024;565:292\u2013300.","journal-title":"Neuroscience"},{"key":"3608_CR2","doi-asserted-by":"publisher","first-page":"15013","DOI":"10.1038\/npjparkd.2015.13","volume":"1","author":"P Zis","year":"2015","unstructured":"Zis P, Erro R, Walton CC, Sauerbier A, Chaudhuri KR. The range and nature of non-motor symptoms in drug-naive parkinson\u2019s disease patients: a state-of-the-art systematic review. NPJ Park Dis. 2015;1:15013.","journal-title":"NPJ Park Dis"},{"key":"3608_CR3","doi-asserted-by":"publisher","first-page":"101840","DOI":"10.1016\/j.arr.2022.101840","volume":"85","author":"MH Ahmad","year":"2023","unstructured":"Ahmad MH, Rizvi MA, Ali M, Mondal AC. Neurobiology of depression in parkinson\u2019s disease: insights into epidemiology, molecular mechanisms and treatment strategies. Ageing Res Rev. 2023;85:101840.","journal-title":"Ageing Res Rev"},{"key":"3608_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/mdc3.14227","volume":"11","author":"V Couture","year":"2024","unstructured":"Couture V, Carmel J-F, Rousseau K, L\u00e9tourneau G, Clerc D, Huot P, et al. Sex differences in neuropsychiatric symptoms in Alpha-Synucleinopathies: A systematic review and Meta-Analysis. Mov Disord Clin Pract. 2024;11:1335\u201344.","journal-title":"Mov Disord Clin Pract"},{"key":"3608_CR5","doi-asserted-by":"publisher","first-page":"615075","DOI":"10.3389\/fcimb.2021.615075","volume":"11","author":"Y Huang","year":"2021","unstructured":"Huang Y, Liao J, Liu X, Zhong Y, Cai X, Long L. Review: the role of intestinal dysbiosis in parkinson\u2019s disease. Front Cell Infect Microbiol. 2021;11:615075.","journal-title":"Front Cell Infect Microbiol"},{"key":"3608_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00415-025-13138-5","volume":"272","author":"PJ Oliver","year":"2025","unstructured":"Oliver PJ, Civitelli L, Hu MT. The gut-brain axis in early parkinson\u2019s disease: from prodrome to prevention. J Neurol. 2025;272:413.","journal-title":"J Neurol"},{"key":"3608_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40266-022-00942-1","volume":"39","author":"S Prange","year":"2022","unstructured":"Prange S, Klinger H, Laurencin C, Danaila T, Thobois S. Depression in patients with parkinson\u2019s disease: current Understanding of its neurobiology and implications for treatment. Drugs Aging. 2022;39:417\u201339.","journal-title":"Drugs Aging"},{"key":"3608_CR8","unstructured":"Sancho-Alonso M, Sarri\u00e9s-Serrano U, Miquel-Rio L, Yan\u00e9s C, Paz V, Javier Meana J et al. New insights into the effects of serotonin on parkinson\u2019s disease and depression through its role in the Gastrointestinal tract. Span J Psychiatry Ment Health. 2024:S2950-2853(24)00039\u2009\u2013\u20095."},{"key":"3608_CR9","first-page":"455","volume":"11","author":"P Borghammer","year":"2021","unstructured":"Borghammer P. The \u03b1-Synuclein origin and connectome model (SOC model) of parkinson\u2019s disease: explaining motor Asymmetry, Non-Motor Phenotypes, and cognitive decline. J Park Dis. 2021;11:455\u201374.","journal-title":"J Park Dis"},{"key":"3608_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"3608_CR11","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager J, Andersen KB, Knudsen K, Skj\u00e6rb\u00e6k C, Fedorova TD, Okkels N, et al. Brain-first versus body-first parkinson\u2019s disease: a multimodal imaging case-control study. Brain. 2020;143:3077\u201388.","journal-title":"Brain"},{"key":"3608_CR12","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/mdc3.70029","volume":"12","author":"E Menozzi","year":"2025","unstructured":"Menozzi E, Schapira AHV, Borghammer P. The Gut-Brain axis in Parkinson disease: emerging concepts and therapeutic implications. Mov Disord Clin Pract. 2025;12:904\u201316.","journal-title":"Mov Disord Clin Pract"},{"key":"3608_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","volume":"510","author":"GM Halliday","year":"1990","unstructured":"Halliday GM, Blumbergs PC, Cotton RG, Blessing WW, Geffen LB. Loss of brainstem serotonin- and substance P-containing neurons in parkinson\u2019s disease. Brain Res. 1990;510:104\u20137.","journal-title":"Brain Res"},{"key":"3608_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.410270405","volume":"27","author":"GM Halliday","year":"1990","unstructured":"Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RG, Howe PR, et al. Neuropathology of immunohistochemically identified brainstem neurons in parkinson\u2019s disease. Ann Neurol. 1990;27:373\u201385.","journal-title":"Ann Neurol"},{"key":"3608_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/biomedicines11020541","volume":"11","author":"L Miquel-Rio","year":"2023","unstructured":"Miquel-Rio L, Sarri\u00e9s-Serrano U, Pavia-Collado R, Meana JJ, Bortolozzi A. The role of \u03b1-Synuclein in the regulation of serotonin system: physiological and pathological features. Biomedicines. 2023;11:541.","journal-title":"Biomedicines"},{"key":"3608_CR16","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1093\/brain\/awac256","volume":"145","author":"JM Shine","year":"2022","unstructured":"Shine JM, O\u2019Callaghan C, Walpola IC, Wainstein G, Taylor N, Aru J, et al. Understanding the effects of serotonin in the brain through its role in the Gastrointestinal tract. Brain J Neurol. 2022;145:2967\u201381.","journal-title":"Brain J Neurol"},{"key":"3608_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41380-022-01806-1","volume":"28","author":"GR Fries","year":"2023","unstructured":"Fries GR, Saldana VA, Finnstein J, Rein T. Molecular pathways of major depressive disorder converge on the synapse. Mol Psychiatry. 2023;28:284\u201397.","journal-title":"Mol Psychiatry"},{"key":"3608_CR18","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"V Krishnan","year":"2008","unstructured":"Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455:894\u2013902.","journal-title":"Nature"},{"key":"3608_CR19","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1093\/brain\/aww162","volume":"139","author":"A Maillet","year":"2016","unstructured":"Maillet A, Krack P, Lhomm\u00e9e E, M\u00e9t\u00e9reau E, Klinger H, Favre E, et al. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de Novo parkinson\u2019s disease. Brain J Neurol. 2016;139:2486\u2013502.","journal-title":"Brain J Neurol"},{"key":"3608_CR20","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.parkreldis.2015.05.016","volume":"21","author":"Q Tong","year":"2015","unstructured":"Tong Q, Zhang L, Yuan Y, Jiang S, Zhang R, Xu Q, et al. Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in parkinson\u2019s disease are associated with nonmotor symptoms. Parkinsonism Relat Disord. 2015;21:882\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"3608_CR21","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/hbm.26139","volume":"44","author":"J Wang","year":"2023","unstructured":"Wang J, Sun J, Gao L, Zhang D, Chen L, Wu T. Common and unique dysconnectivity profiles of dorsal and median Raphe in parkinson\u2019s disease. Hum Brain Mapp. 2023;44:1070\u20138.","journal-title":"Hum Brain Mapp"},{"key":"3608_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41398-022-01842-z","volume":"12","author":"L Miquel-Rio","year":"2022","unstructured":"Miquel-Rio L, Alarc\u00f3n-Ar\u00eds D, Torres-L\u00f3pez M, C\u00f3ppola-Segovia V, Pavia-Collado R, Paz V, et al. Human \u03b1-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy. Transl Psychiatry. 2022;12:79.","journal-title":"Transl Psychiatry"},{"key":"3608_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41531-025-01073-1","volume":"11","author":"L Miquel-Rio","year":"2025","unstructured":"Miquel-Rio L, Jeric\u00f3-Escolar J, Sarri\u00e9s-Serrano U, Yanes-Castilla C, Torres-L\u00f3pez M, Argibay U, et al. Early synaptic changes and reduced brain connectivity in PD-like mice with depressive phenotype. NPJ Park Dis. 2025;11:242.","journal-title":"NPJ Park Dis"},{"key":"3608_CR24","doi-asserted-by":"publisher","first-page":"1103053","DOI":"10.3389\/fimmu.2023.1103053","volume":"14","author":"M Li","year":"2023","unstructured":"Li M, Wan J, Xu Z, Tang B. The association between parkinson\u2019s disease and autoimmune diseases: A systematic review and meta-analysis. Front Immunol. 2023;14:1103053.","journal-title":"Front Immunol"},{"key":"3608_CR25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4103\/1673-5374.317981","volume":"17","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Yuan M, Liu Y, Yang F, Chen W-Z, Xu Z-Z, et al. Association between inflammatory bowel diseases and parkinson\u2019s disease: systematic review and meta-analysis. Neural Regen Res. 2022;17:344\u201353.","journal-title":"Neural Regen Res"},{"key":"3608_CR26","doi-asserted-by":"publisher","first-page":"e12962","DOI":"10.1111\/nan.12962","volume":"50","author":"AM Espinosa-Oliva","year":"2024","unstructured":"Espinosa-Oliva AM, Ruiz R, Soto MS, Boza-Serrano A, Rodriguez-Perez AI, Roca-Ceballos MA, et al. Inflammatory bowel disease induces pathological \u03b1-synuclein aggregation in the human gut and brain. Neuropathol Appl Neurobiol. 2024;50:e12962.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3608_CR27","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/jgh.15855","volume":"37","author":"B Zhang","year":"2022","unstructured":"Zhang B, Wang H-HE, Bai Y-M, Tsai S-J, Su T-P, Chen T-J, et al. Bidirectional association between inflammatory bowel disease and depression among patients and their unaffected siblings. J Gastroenterol Hepatol. 2022;37:1307\u201315.","journal-title":"J Gastroenterol Hepatol"},{"key":"3608_CR28","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/ibd\/izae206","volume":"31","author":"S Massironi","year":"2025","unstructured":"Massironi S, Pigoni A, Vegni EAM, Keefer L, Dubinsky MC, Brambilla P, et al. The burden of psychiatric manifestations in inflammatory bowel diseases: A systematic review with Meta-analysis. Inflamm Bowel Dis. 2025;31:1441\u201359.","journal-title":"Inflamm Bowel Dis"},{"key":"3608_CR29","doi-asserted-by":"crossref","unstructured":"Neuendorf R, Harding A, Stello N, Hanes D, Wahbeh H. Depression and anxiety in patients with inflammatory bowel disease: A systematic review. J Psychosom Res. 2016;87.","DOI":"10.1016\/j.jpsychores.2016.06.001"},{"key":"3608_CR30","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/ibd\/izad109","volume":"30","author":"D Piovani","year":"2024","unstructured":"Piovani D, Armuzzi A, Bonovas S. Association of depression with incident inflammatory bowel diseases: A systematic review and Meta-Analysis. Inflamm Bowel Dis. 2024;30:573\u201384.","journal-title":"Inflamm Bowel Dis"},{"key":"3608_CR31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22:657\u201373.","journal-title":"Nat Rev Immunol"},{"key":"3608_CR32","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1093\/brain\/awab156","volume":"144","author":"Q Wang","year":"2021","unstructured":"Wang Q, Luo Y, Ray Chaudhuri K, Reynolds R, Tan E-K, Pettersson S. The role of gut dysbiosis in parkinson\u2019s disease: mechanistic insights and therapeutic options. Brain. 2021;144:2571\u201393.","journal-title":"Brain"},{"key":"3608_CR33","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/JLB.3RU0120-090RR","volume":"110","author":"NL Morris","year":"2021","unstructured":"Morris NL, Choudhry MA. Maintenance of gut barrier integrity after injury: trust your gut MicroRNAs. J Leukoc Biol. 2021;110:979\u201386.","journal-title":"J Leukoc Biol"},{"key":"3608_CR34","doi-asserted-by":"crossref","unstructured":"Wang J, Xu F, Zhu X, Li X, Li Y, Li J. Targeting MicroRNAs to regulate the integrity of the Blood\u2013Brain barrier. Front Bioeng Biotechnol. 2021;9.","DOI":"10.3389\/fbioe.2021.673415"},{"key":"3608_CR35","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/cr.2017.62","volume":"27","author":"B Xu","year":"2017","unstructured":"Xu B, Zhang Y, Du X-F, Li J, Zi H-X, Bu J-W, et al. Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity. Cell Res. 2017;27:882\u201397.","journal-title":"Cell Res"},{"key":"3608_CR36","doi-asserted-by":"publisher","first-page":"e0154351","DOI":"10.1371\/journal.pone.0154351","volume":"11","author":"RJ Haines Jr","year":"2016","unstructured":"Haines RJ Jr, Eitner RSB, Chen RA, Wu L. TNF\u03b1\/IFN\u03b3 mediated intestinal epithelial barrier dysfunction is attenuated by MicroRNA-93 downregulation of PTK6 in mouse colonic epithelial cells. PLoS ONE. 2016;11:e0154351.","journal-title":"PLoS ONE"},{"key":"3608_CR37","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1053\/j.gastro.2019.02.023","volume":"156","author":"Y Tian","year":"2019","unstructured":"Tian Y, Xu J, Li Y, Zhao R, Du S, Lv C, et al. MicroRNA-31 reduces inflammatory signaling and promotes regeneration in colon Epithelium, and delivery of mimics in microspheres reduces colitis in mice. Gastroenterology. 2019;156:2281\u2013e22966.","journal-title":"Gastroenterology"},{"key":"3608_CR38","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1159\/000478629","volume":"42","author":"B Zhang","year":"2017","unstructured":"Zhang B, Tian Y, Jiang P, Jiang Y, Li C, Liu T, et al. MicroRNA-122a regulates Zonulin by targeting EGFR in intestinal epithelial dysfunction. Cell Physiol Biochem. 2017;42:848\u201358.","journal-title":"Cell Physiol Biochem"},{"key":"3608_CR39","doi-asserted-by":"crossref","unstructured":"Fu X, Niu T, Li X. MicroRNA-126-3p attenuates intracerebral Hemorrhage-Induced Blood-Brain barrier disruption by regulating VCAM-1 expression. Front Neurosci. 2019;13.","DOI":"10.3389\/fnins.2019.00866"},{"key":"3608_CR40","doi-asserted-by":"publisher","first-page":"106870","DOI":"10.1016\/j.phrs.2023.106870","volume":"194","author":"N Datta","year":"2023","unstructured":"Datta N, Johnson C, Kao D, Gurnani P, Alexander C, Polytarchou C, et al. MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis. Pharmacol Res. 2023;194:106870.","journal-title":"Pharmacol Res"},{"key":"3608_CR41","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1136\/gutjnl-2022-327301","volume":"73","author":"TM Monaghan","year":"2024","unstructured":"Monaghan TM, Ugun-Klusek A, Finelli M, Gurnani P, Chakrabarti L, Kao D, et al. Connecting inflammatory bowel and neurodegenerative diseases: MicroRNAs as a shared therapeutic intervention. Gut. 2024;73:1034\u20136.","journal-title":"Gut"},{"key":"3608_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1113\/JP282627","volume":"601","author":"L Alexander","year":"2023","unstructured":"Alexander L, Wood CM, Roberts AC. The ventromedial prefrontal cortex and emotion regulation: lost in translation? J Physiol. 2023;601:37\u201350.","journal-title":"J Physiol"},{"key":"3608_CR43","doi-asserted-by":"publisher","first-page":"102130","DOI":"10.1016\/j.nicl.2019.102130","volume":"25","author":"H Lin","year":"2020","unstructured":"Lin H, Cai X, Zhang D, Liu J, Na P, Li W. Functional connectivity markers of depression in advanced parkinson\u2019s disease. NeuroImage Clin. 2020;25:102130.","journal-title":"NeuroImage Clin"},{"key":"3608_CR44","doi-asserted-by":"publisher","first-page":"111299","DOI":"10.1016\/j.pnpbp.2025.111299","volume":"138","author":"U Sarri\u00e9s-Serrano","year":"2025","unstructured":"Sarri\u00e9s-Serrano U, Miquel-Rio L, Santana N, Paz V, Sancho-Alonso M, Callado LF, et al. Impaired unfolded protein response, BDNF and synuclein markers in postmortem dorsolateral prefrontal cortex and caudate nucleus of patients with depression and parkinson\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2025;138:111299.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3608_CR45","doi-asserted-by":"publisher","first-page":"101028","DOI":"10.1016\/j.nsa.2023.101028","volume":"2","author":"US Serrano","year":"2023","unstructured":"Serrano US, Miquel-Rio L, Paz V, Meana JJ, Bortolozzi A. Sex-based modulation of Endoplasmic reticulum stress and antidepressant response in a mouse model of \u03b1-synucleinopathy. Neurosci Appl. 2023;2:101028.","journal-title":"Neurosci Appl"},{"key":"3608_CR46","doi-asserted-by":"crossref","unstructured":"Miquel-Rio L, Sarri\u00e9s-Serrano U, Sancho-Alonso M, Florensa-Zanuy E, Paz V, Ruiz-Bronchal E et al. ER-stress in mouse serotonin neurons triggers a depressive phenotype alleviated by ketamine targeting eIF2\u03b1 signaling. iScience. 2024. 2024.","DOI":"10.1016\/j.isci.2024.109787"},{"key":"3608_CR47","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/mp.2015.80","volume":"21","author":"A Ferr\u00e9s-Coy","year":"2016","unstructured":"Ferr\u00e9s-Coy A, Galofr\u00e9 M, Pilar-Cu\u00e9llar F, Vidal R, Paz V, Ruiz-Bronchal E, et al. Therapeutic antidepressant potential of a conjugated SiRNA Silencing the serotonin transporter after intranasal administration. Mol Psychiatry. 2016;21:328\u201338.","journal-title":"Mol Psychiatry"},{"key":"3608_CR48","doi-asserted-by":"crossref","unstructured":"McFleder RL, Makhotkina A, Groh J, Keber U, Imdahl F, Pe\u00f1a Mosca J et al. Brain-to-gut trafficking of alpha-synuclein by CD11c\u2009+\u2009cells in a mouse model of parkinson\u2019s disease. Nat Commun. 2023;14.","DOI":"10.1038\/s41467-023-43224-z"},{"key":"3608_CR49","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.3390\/ijms24054508","volume":"24","author":"SI Marques","year":"2023","unstructured":"Marques SI, Carmo H, Carvalho F, S\u00e1 SI, Silva JP. A Semi-Automatic method for the quantification of astrocyte number and branching in bulk immunohistochemistry images. Int J Mol Sci. 2023;24:4508.","journal-title":"Int J Mol Sci"},{"key":"3608_CR50","doi-asserted-by":"publisher","first-page":"220200","DOI":"10.1098\/rsob.220200","volume":"13","author":"A Martinez","year":"2023","unstructured":"Martinez A, H\u00e9rich\u00e9 J-K, Calvo M, Tischer C, Otxoa-de-Amezaga A, Pedragosa J, et al. Characterization of microglia behaviour in healthy and pathological conditions with image analysis tools. Open Biol. 2023;13:220200.","journal-title":"Open Biol"},{"key":"3608_CR51","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/gutjnl-2013-306464","volume":"65","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Yang L, Larson S, Basra S, Merwat S, Tan A, et al. Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1. Gut. 2016;65:797\u2013805.","journal-title":"Gut"},{"key":"3608_CR52","doi-asserted-by":"publisher","first-page":"656","DOI":"10.5056\/jnm18037","volume":"24","author":"Q Hou","year":"2018","unstructured":"Hou Q, Huang Y, Zhang C, Zhu S, Li P, Chen X, et al. MicroRNA-200a targets cannabinoid receptor 1 and serotonin transporter to increase visceral hyperalgesia in Diarrhea-predominant irritable bowel syndrome rats. J Neurogastroenterol Motil. 2018;24:656\u201368.","journal-title":"J Neurogastroenterol Motil"},{"key":"3608_CR53","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/gut.2004.039826","volume":"53","author":"M Camilleri","year":"2004","unstructured":"Camilleri M. Is there a SERT-ain association with IBS? Gut. 2004;53:1396\u20139.","journal-title":"Gut"},{"key":"3608_CR54","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fncel.2018.00247","volume":"12","author":"SA Ferreira","year":"2018","unstructured":"Ferreira SA, Romero-Ramos M. Microglia response during parkinson\u2019s disease: Alpha-Synuclein intervention. Front Cell Neurosci. 2018;12:247.","journal-title":"Front Cell Neurosci"},{"key":"3608_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12964-023-01402-y","volume":"22","author":"Y Miao","year":"2024","unstructured":"Miao Y, Meng H. The involvement of \u03b1-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of parkinson\u2019s disease. Cell Commun Signal CCS. 2024;22:31.","journal-title":"Cell Commun Signal CCS"},{"key":"3608_CR56","doi-asserted-by":"publisher","first-page":"4750","DOI":"10.3390\/ijms26104750","volume":"26","author":"A Sokal-Dembowska","year":"2025","unstructured":"Sokal-Dembowska A, Jarmakiewicz-Czaja S, Helma K, Filip R. The role of MicroRNAs in inflammatory bowel disease. Int J Mol Sci. 2025;26:4750.","journal-title":"Int J Mol Sci"},{"key":"3608_CR57","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1136\/gutjnl-2014-307891","volume":"64","author":"R Kalla","year":"2015","unstructured":"Kalla R, Ventham NT, Kennedy NA, Quintana JF, Nimmo ER, Buck AH, et al. MicroRNAs: new players in IBD. Gut. 2015;64:504\u201317.","journal-title":"Gut"},{"key":"3608_CR58","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.3748\/wjg.v30.i16.2184","volume":"30","author":"ECS de Oliveira","year":"2024","unstructured":"de Oliveira ECS, Quaglio AEV, Grillo TG, Di Stasi LC, Sassaki LY. MicroRNAs in inflammatory bowel disease: what do we know and what can we expect? World J Gastroenterol. 2024;30:2184\u201390.","journal-title":"World J Gastroenterol"},{"key":"3608_CR59","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/mds.26321","volume":"30","author":"Y Lou","year":"2015","unstructured":"Lou Y, Huang P, Li D, Cen Z, Wang B, Gao J, et al. Altered brain network centrality in depressed parkinson\u2019s disease patients. Mov Disord Off J Mov Disord Soc. 2015;30:1777\u201384.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"3608_CR60","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/cns.13467","volume":"27","author":"Y-H Qiu","year":"2021","unstructured":"Qiu Y-H, Huang Z-H, Gao Y-Y, Feng S-J, Huang B, Wang W-Y, et al. Alterations in intrinsic functional networks in parkinson\u2019s disease patients with depression: A resting-state functional magnetic resonance imaging study. CNS Neurosci Ther. 2021;27:289\u201398.","journal-title":"CNS Neurosci Ther"},{"key":"3608_CR61","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1093\/ibd\/izac250","volume":"29","author":"J Alfaifi","year":"2023","unstructured":"Alfaifi J, Germain A, Heba A-C, Arnone D, Gailly L, Ndiaye NC, et al. Deep dive into MicroRNAs in inflammatory bowel disease. Inflamm Bowel Dis. 2023;29:986\u201399.","journal-title":"Inflamm Bowel Dis"},{"key":"3608_CR62","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41385-019-0216-7","volume":"13","author":"Y Shi","year":"2020","unstructured":"Shi Y, Dai S, Qiu C, Wang T, Zhou Y, Xue C, et al. MicroRNA-219a-5p suppresses intestinal inflammation through inhibiting Th1\/Th17-mediated immune responses in inflammatory bowel disease. Mucosal Immunol. 2020;13:303\u201312.","journal-title":"Mucosal Immunol"},{"key":"3608_CR63","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1053\/j.gastro.2021.02.040","volume":"160","author":"S Mahurkar-Joshi","year":"2021","unstructured":"Mahurkar-Joshi S, Rankin CR, Videlock EJ, Soroosh A, Verma A, Khandadash A, et al. The colonic mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p are downregulated in irritable bowel syndrome and are associated with barrier function and MAPK signaling. Gastroenterology. 2021;160:2409\u2013e242219.","journal-title":"Gastroenterology"},{"key":"3608_CR64","doi-asserted-by":"publisher","first-page":"1090556","DOI":"10.3389\/fnmol.2023.1090556","volume":"16","author":"Z Li","year":"2023","unstructured":"Li Z, Chen D, Pan R, Zhong Y, Zhong T, Jiao Z. MicroRNAs profiling of small extracellular vesicles from midbrain tissue of parkinson\u2019s disease. Front Mol Neurosci. 2023;16:1090556.","journal-title":"Front Mol Neurosci"},{"key":"3608_CR65","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41386-020-00861-y","volume":"46","author":"Y Yoshino","year":"2021","unstructured":"Yoshino Y, Roy B, Dwivedi Y. Differential and unique patterns of synaptic MiRNA expression in dorsolateral prefrontal cortex of depressed subjects. Neuropsychopharmacology. 2021;46:900\u201310.","journal-title":"Neuropsychopharmacology"},{"key":"3608_CR66","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/pharmaceutics12020186","volume":"12","author":"I Osorio-Querejeta","year":"2020","unstructured":"Osorio-Querejeta I, Carregal-Romero S, Ayerdi-Izquierdo A, M\u00e4ger I, Nash LA, Wood M, et al. MiR-219a-5p enriched extracellular vesicles induce OPC differentiation and EAE improvement more efficiently than liposomes and polymeric nanoparticles. Pharmaceutics. 2020;12:186.","journal-title":"Pharmaceutics"},{"key":"3608_CR67","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1073\/pnas.0805854106","volume":"106","author":"J Kocerha","year":"2009","unstructured":"Kocerha J, Faghihi M, Lopez-Toledano M, Huang J, Ramsey A, Caron M, et al. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci U S A. 2009;106:3507\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3608_CR68","doi-asserted-by":"publisher","first-page":"991346","DOI":"10.3389\/fimmu.2022.991346","volume":"13","author":"\u00c9 Boros","year":"2022","unstructured":"Boros \u00c9, Heged\u0171s Z, Kellermayer Z, Balogh P, Nagy I. Global alteration of colonic MicroRNAome landscape associated with inflammatory bowel disease. Front Immunol. 2022;13:991346.","journal-title":"Front Immunol"},{"key":"3608_CR69","first-page":"1","volume":"32","author":"E Khalil","year":"2023","unstructured":"Khalil E, Shaker O, Hasona N, lncRNA. H-19 and miR-200a implication and frequency of LncRNA H-19 rs2170425 SNP in ulcerative colitis and crohn\u2019s disease. Comp Clin Pathol. 2023;32:1\u20137.","journal-title":"Comp Clin Pathol"},{"key":"3608_CR70","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.crohns.2012.02.006","volume":"6","author":"A Paraskevi","year":"2012","unstructured":"Paraskevi A, Theodoropoulos G, Papaconstantinou I, Mantzaris G, Nikiteas N, Gazouli M. Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis. 2012;6:900\u20134.","journal-title":"J Crohns Colitis"},{"key":"3608_CR71","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/biomedicines12020422","volume":"12","author":"C de S\u00edbia","year":"2024","unstructured":"de S\u00edbia C, de Quaglio F, de Oliveira AEV, Pereira ECS, Ariede JN, Lapa JR. microRNA\u2013mRNA networks linked to inflammation and immune system regulation in inflammatory bowel disease. Biomedicines. 2024;12:422.","journal-title":"Biomedicines"},{"key":"3608_CR72","doi-asserted-by":"publisher","first-page":"153303461877550","DOI":"10.1177\/1533034618775509","volume":"17","author":"QD Zhu","year":"2018","unstructured":"Zhu QD, Zhou QQ, Dong L, Huang Z, Wu F, Deng X. MiR-199a-5p inhibits the growth and metastasis of colorectal cancer cells by targeting ROCK1. Technol Cancer Res Treat. 2018;17:1533034618775509.","journal-title":"Technol Cancer Res Treat"},{"key":"3608_CR73","doi-asserted-by":"publisher","first-page":"868229","DOI":"10.3389\/fimmu.2022.868229","volume":"13","author":"X Xiao","year":"2022","unstructured":"Xiao X, Mao X, Chen DW, Yu B, He J, Yan H, et al. MiRNAs can affect intestinal epithelial barrier in inflammatory bowel disease. Front Immunol. 2022;13:868229.","journal-title":"Front Immunol"},{"key":"3608_CR74","doi-asserted-by":"publisher","first-page":"8275026","DOI":"10.1155\/2020\/8275026","volume":"2020","author":"X Du","year":"2020","unstructured":"Du X, Tian D, Wei J, Yan C, Hu P, Wu X, et al. miR-199a-5p exacerbated intestinal barrier dysfunction through inhibiting surfactant protein D and activating NF-\u03baB pathway in sepsis. Mediators Inflamm. 2020;2020:8275026.","journal-title":"Mediators Inflamm"},{"key":"3608_CR75","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neurobiolaging.2018.05.032","volume":"69","author":"E Tolosa","year":"2018","unstructured":"Tolosa E, Botta-Orfila T, Morat\u00f3 X, Calatayud C, Ferrer-Lorente R, Mart\u00ed M-J, et al. MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients. Neurobiol Aging. 2018;69:283\u201391.","journal-title":"Neurobiol Aging"},{"key":"3608_CR76","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Galdeano T, Reigada D, Gamarra M, Soto A, Barreda-Manso M, Novillo I et al. Identification of A new role of miR-199a-5p as factor implied in neuronal damage: decreasing the expression of its target X-Linked Anti-Apoptotic protein (XIAP) after SCI. 2022.","DOI":"10.20944\/preprints202212.0020.v1"},{"key":"3608_CR77","doi-asserted-by":"publisher","first-page":"e02107","DOI":"10.1002\/brb3.2107","volume":"11","author":"Z Liu","year":"2021","unstructured":"Liu Z, Yang J, Fang Q, Shao H, Yang D, Sun J, et al. MiRNA-199a-5p targets WNT2 to regulate depression through the CREB\/BDNF signaling in hippocampal neuron. Brain Behav. 2021;11:e02107.","journal-title":"Brain Behav"},{"key":"3608_CR78","doi-asserted-by":"crossref","unstructured":"Li Q, Galbraith D, Morrison R, Trivedi M, Drevets W. Circulating MicroRNA associated with future relapse status in major depressive disorder. Front Psychiatry. 2022;13.","DOI":"10.3389\/fpsyt.2022.937360"},{"key":"3608_CR79","doi-asserted-by":"publisher","first-page":"e548","DOI":"10.1002\/mgg3.548","volume":"7","author":"M Talepoor Ardakani","year":"2019","unstructured":"Talepoor Ardakani M, Rostamian Delavar M, Baghi M, Nasr-Esfahani MH, Kiani-Esfahani A, Ghaedi K. Upregulation of miR-200a and miR-204 in MPP+ -treated differentiated PC12 cells as a model of parkinson\u2019s disease. Mol Genet Genomic Med. 2019;7:e548.","journal-title":"Mol Genet Genomic Med"},{"key":"3608_CR80","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbi.2019.08.190","volume":"82","author":"SK Satyanarayanan","year":"2019","unstructured":"Satyanarayanan SK, Shih Y-H, Wen Y-R, Palani M, Lin Y-W, Su H, et al. miR-200a-3p modulates gene expression in comorbid pain and depression: molecular implication for central sensitization. Brain Behav Immun. 2019;82:230\u20138.","journal-title":"Brain Behav Immun"},{"key":"3608_CR81","doi-asserted-by":"crossref","unstructured":"Stapel B, Xiao K, Gorinski N, Schmidt K, Pfanne A, Fiedler J et al. MicroRNAs as novel peripheral markers for suicidality in patients with major depressive disorder. Front Psychiatry. 2022;13.","DOI":"10.3389\/fpsyt.2022.1020530"},{"key":"3608_CR82","first-page":"1811","volume":"44","author":"J Yu","year":"2019","unstructured":"Yu J, Chen J, Yang H, Chen S, Wang Z. Overexpression of miR-200a-3p promoted inflammation in sepsis-induced brain injury through ROS-induced NLRP3. Int J Mol Med. 2019;44:1811\u201323.","journal-title":"Int J Mol Med"},{"key":"3608_CR83","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12038-017-9698-1","volume":"42","author":"Q-S Zhang","year":"2017","unstructured":"Zhang Q-S, Liu W, Lu G-X. miR-200a-3p promotes b-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in alzheimer\u2019s disease. J Biosci. 2017;42:397\u2013404.","journal-title":"J Biosci"},{"key":"3608_CR84","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gene.2018.06.061","volume":"674","author":"N Salimian","year":"2018","unstructured":"Salimian N, Peymani M, Ghaedi K, Nasr Esfahani MH. Modulation in miR-200a\/SIRT1axis is associated with apoptosis in MPP+-induced SH-SY5Y cells. Gene. 2018;674:25\u201330.","journal-title":"Gene"},{"key":"3608_CR85","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.14336\/AD.2020.0216","volume":"11","author":"X Li","year":"2020","unstructured":"Li X, Feng Y, Wang X-X, Truong D, Wu Y-C. The critical role of SIRT1 in parkinson\u2019s disease: mechanism and therapeutic considerations. Aging Dis. 2020;11:1608.","journal-title":"Aging Dis"},{"key":"3608_CR86","doi-asserted-by":"publisher","first-page":"102545","DOI":"10.1016\/j.arr.2024.102545","volume":"102","author":"R Thapa","year":"2024","unstructured":"Thapa R, Moglad E, Afzal M, Gupta G, Bhat AA, Hassan Almalki W, et al. The role of Sirtuin 1 in ageing and neurodegenerative disease: A molecular perspective. Ageing Res Rev. 2024;102:102545.","journal-title":"Ageing Res Rev"},{"key":"3608_CR87","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12868-025-00968-2","volume":"26","author":"L Sun","year":"2025","unstructured":"Sun L, Li C, Shi J, Zeng W, Wu L, Wan S, et al. SRT1720 ameliorates LPS-induced depressive-like behaviors in mice and activates Parkin-mediated mitophagy. BMC Neurosci. 2025;26:56.","journal-title":"BMC Neurosci"},{"key":"3608_CR88","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/bs.pbr.2022.01.013","volume":"269","author":"I Frouni","year":"2022","unstructured":"Frouni I, Kwan C, Belliveau S, Huot P. Cognition and serotonin in parkinson\u2019s disease. Prog Brain Res. 2022;269:373\u2013403.","journal-title":"Prog Brain Res"},{"key":"3608_CR89","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/mds.23083","volume":"25","author":"P Huot","year":"2010","unstructured":"Huot P, Johnston TH, Darr T, Hazrati L-N, Visanji NP, Pires D, et al. Increased 5-HT2A receptors in the Temporal cortex of parkinsonian patients with visual hallucinations. Mov Disord. 2010;25:1399\u2013408.","journal-title":"Mov Disord"},{"key":"3608_CR90","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.neuropharm.2014.08.009","volume":"86","author":"C Muguruza","year":"2014","unstructured":"Muguruza C, Miranda-Azpiazu P, D\u00edez-Alarcia R, Morentin B, Gonz\u00e1lez-Maeso J, Callado LF, et al. Evaluation of 5-HT2A and mGlu2\/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment. Neuropharmacology. 2014;86:311\u20138.","journal-title":"Neuropharmacology"},{"key":"3608_CR91","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1176\/ajp.2006.163.9.1580","volume":"163","author":"Z Bhagwagar","year":"2006","unstructured":"Bhagwagar Z, Hinz R, Taylor M, Fancy S, Cowen P, Grasby P. Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907. Am J Psychiatry. 2006;163:1580\u20137.","journal-title":"Am J Psychiatry"},{"key":"3608_CR92","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12974-025-03462-y","volume":"22","author":"F Lind-Holm Mogensen","year":"2025","unstructured":"Lind-Holm Mogensen F, Seibler P, Gr\u00fcnewald A, Michelucci A. Microglial dynamics and neuroinflammation in prodromal and early parkinson\u2019s disease. J Neuroinflammation. 2025;22:136.","journal-title":"J Neuroinflammation"},{"key":"3608_CR93","doi-asserted-by":"publisher","first-page":"1476461","DOI":"10.3389\/fncel.2024.1476461","volume":"18","author":"RR Samant","year":"2024","unstructured":"Samant RR, Standaert DG, Harms AS. The emerging role of disease-associated microglia in parkinson\u2019s disease. Front Cell Neurosci. 2024;18:1476461.","journal-title":"Front Cell Neurosci"},{"key":"3608_CR94","doi-asserted-by":"publisher","first-page":"106145","DOI":"10.1016\/j.phrs.2022.106145","volume":"179","author":"B Li","year":"2022","unstructured":"Li B, Yang W, Ge T, Wang Y, Cui R. Stress induced microglial activation contributes to depression. Pharmacol Res. 2022;179:106145.","journal-title":"Pharmacol Res"},{"key":"3608_CR95","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12974-022-02492-0","volume":"19","author":"H Wang","year":"2022","unstructured":"Wang H, He Y, Sun Z, Ren S, Liu M, Wang G, et al. Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression. J Neuroinflammation. 2022;19:132.","journal-title":"J Neuroinflammation"},{"key":"3608_CR96","doi-asserted-by":"crossref","unstructured":"Xu K, Li Y, Zhou Y, Zhang Y, Shi Y, Zhang C et al. Neuroinflammation in parkinson\u2019s disease: focus on the relationship between MiRNAs and microglia. Front Cell Neurosci. 2024;18.","DOI":"10.3389\/fncel.2024.1429977"},{"key":"3608_CR97","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13024-025-00816-1","volume":"20","author":"MS Sirerol-Piquer","year":"2025","unstructured":"Sirerol-Piquer MS, Perez-Villalba A, Duart-Abadia P, Belenguer G, G\u00f3mez-Pinedo U, Blasco-Chamarro L, et al. Age-dependent progression from clearance to vulnerability in the early response of periventricular microglia to \u03b1-synuclein toxic species. Mol Neurodegener. 2025;20:26.","journal-title":"Mol Neurodegener"},{"key":"3608_CR98","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S. Neuroinflammation in parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 2009;8:382\u201397.","journal-title":"Lancet Neurol"},{"key":"3608_CR99","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0079-6123(08)61770-7","volume":"94","author":"LS Forno","year":"1992","unstructured":"Forno LS, DeLanney LE, Irwin I, Di Monte D, Langston JW. Astrocytes and parkinson\u2019s disease. Prog Brain Res. 1992;94:429\u201336.","journal-title":"Prog Brain Res"},{"key":"3608_CR100","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3390\/cells14171342","volume":"14","author":"JH Lee","year":"2025","unstructured":"Lee JH, Chang W, Min SS, Song DY, Yoo HI. Beyond support cells: astrocytic autophagy as a central regulator of CNS homeostasis and neurodegenerative diseases. Cells. 2025;14:1342.","journal-title":"Cells"},{"key":"3608_CR101","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1002\/glia.23994","volume":"69","author":"LA O\u2019Leary","year":"2021","unstructured":"O\u2019Leary LA, Mechawar N. Implication of cerebral astrocytes in major depression: A review of fine neuroanatomical evidence in humans. Glia. 2021;69:2077\u201399.","journal-title":"Glia"},{"key":"3608_CR102","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/glia.23593","volume":"67","author":"MN Fullana","year":"2019","unstructured":"Fullana MN, Ruiz-Bronchal E, Ferr\u00e9s-Coy A, Ju\u00e1rez-Escoto E, Artigas F, Bortolozzi A. Regionally selective knockdown of astroglial glutamate transporters in infralimbic cortex induces a depressive phenotype in mice. Glia. 2019;67:1122\u201337.","journal-title":"Glia"},{"key":"3608_CR103","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.euroneuro.2019.09.004","volume":"29","author":"MN Fullana","year":"2019","unstructured":"Fullana MN, Covelo A, Bortolozzi A, Araque A, Artigas F. In vivo knockdown of astroglial glutamate transporters GLT-1 and GLAST increases excitatory neurotransmission in mouse infralimbic cortex: relevance for depressive-like phenotypes. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 2019;29:1288\u201394.","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"3608_CR104","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.tins.2009.05.001","volume":"32","author":"G Perea","year":"2009","unstructured":"Perea G, Navarrete M, Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci. 2009;32:421\u201331.","journal-title":"Trends Neurosci"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03608-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03608-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03608-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:03:04Z","timestamp":1762300984000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-025-03608-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3608"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03608-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7771648\/v1","asserted-by":"object"}]},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Postmortem human brain samples.The study was approved by the Ethics Committee of Spanish National Research Council (Project Ref. PID2019-105136RB-I00). The dorsolateral prefrontal cortex (dlPFC) and caudate nucleus (CAU) tissue samples from controls and PD patients were obtained from the Hospital Clinic-IDIBAPS biobank, in accordance with Spanish legislation and with the approval of the local ethics committees. Pathological cases were categorized as stages 1\u20136 of LB disease pathology, according to Braak staining (Braak et al., 2003), excluding tauopathies, vascular disease, and metabolic syndrome. Cases in the control group had not neurological, psychiatric, or metabolic disorders and no neuropathological abnormalities, except for sporadic Alzheimer\u2019s disease. A total of 10 control and 20 cases with PD-related pathology were included in the present study. All PD cases were treated for motor symptoms. See Table\u00a01 for subject details.In addition, dlPFC and CAU tissue samples were obtained at autopsy from non-psychiatric controls and DD patients at the Basque Institute of Legal Medicine, Bilbao, Spain, in accordance with the Spanish guidelines of research and ethics committees for postmortem brain studies. This study used dlPFC and CAU from a total of 28 controls and 28 subjects with DD. Of the 28 subjects with MDD, 23 died by suicide. Cohort characteristics are shown in\n                      Table\u00a01\n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}